- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 413/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 413/06
Total number of patents in this class: 2143
10-year publication summary
|
190
|
186
|
139
|
161
|
169
|
158
|
113
|
130
|
139
|
36
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
54 |
| VALO Health, Inc. | 147 |
51 |
| Janssen Pharmaceutica N.V. | 3839 |
49 |
| Merck Sharp & Dohme LLC | 3689 |
46 |
| F. Hoffmann-La Roche AG | 7958 |
44 |
| Bristol-myers Squibb Company | 5080 |
41 |
| Boehringer Ingelheim International GmbH | 4629 |
40 |
| Novartis AG | 11238 |
28 |
| Merck Patent GmbH | 5909 |
27 |
| Hoffmann-La Roche Inc. | 3060 |
24 |
| Achillion Pharmaceuticals, Inc. | 176 |
23 |
| AstraZeneca AB | 3042 |
18 |
| Gilead Sciences, Inc. | 1879 |
18 |
| Incyte Corporation | 918 |
18 |
| Pfizer Inc. | 3322 |
17 |
| Abbvie Inc. | 1808 |
16 |
| Shionogi & Co., Ltd. | 914 |
16 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
16 |
| ChemoCentryx, Inc. | 400 |
14 |
| The Regents of the University of California | 18943 |
13 |
| Other owners | 1570 |